Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. - Wikidata - awgldk - TriplyDB

Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

http://www.wikidata.org/entity/Q47431942

about

Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid Intermediates Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight Sphingolipids in High Fat Diet and Obesity-Related Diseases Glucose induces sensitivity to oxygen deprivation and modulates insulin/IGF-1 signaling and lipid biosynthesis in Caenorhabditis elegans.From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism Lipidomics-Reshaping the Analysis and Perception of Type 2 Diabetes Regulation of Nlrp3 inflammasome by dietary metabolites The cell biology of fat expansion Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner Differential network analysis with multiply imputed lipidomic data Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.Glucose or Altered Ceramide Biosynthesis Mediate Oxygen Deprivation Sensitivity Through Novel Pathways Revealed by Transcriptome Analysis in Caenorhabditis elegans.Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome.Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot study Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.De Novo Lipogenesis Products and Endogenous Lipokines.C16:0-ceramide signals insulin resistance Dietary Very Long Chain Saturated Fatty Acids and Metabolic Factors: Findings from the Korea National Health and Nutrition Examination Survey 2013.Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice.Alterations of the Lipid Metabolome in Dairy Cows Experiencing Excessive Lipolysis Early Postpartum.Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice.An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.Interictal, circulating sphingolipids in women with episodic migraine: A case-control study.Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo.An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.Temporal changes in sphingolipids and systemic insulin sensitivity during the transition from gestation to lactation Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction Glycosphingolipids and cell death: one aim, many ways The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease Fenretinide mediated retinoic acid receptor signalling and inhibition of ceramide biosynthesis regulates adipogenesis, lipid accumulation, mitochondrial function and nutrient stress signalling in adipocytes and adipose tissue.Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis.Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea).Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.

P2860

Q26739957-4EC33418-E2AD-4487-A5BA-F7D89B68A4A6 Q26752583-A28B7081-1D80-4C50-802D-AFCA48E6FA51 Q26773230-F6A7043D-0034-4E2F-9F0A-B91341E21477 Q27346465-ECAA8BD8-FBCE-4040-A9C2-19FA2CFB6862 Q28067617-BC01B71B-0C22-46F0-B4C2-B196908F4EFE Q28073169-C0351207-2542-439C-8C34-8C392279ACB5 Q28078340-358518F5-0F7A-4EFF-8061-95AB7DC1A027 Q28084054-0D2FFE1F-C793-405E-811F-D919B8B0C9F2 Q28547365-973CE501-7C9E-4B98-86A2-2B824527D608 Q28550974-95152422-A291-48BD-8BA2-3B12DA60729E Q28552611-1A342DE4-05AC-4A0D-999E-D6FA4263A855 Q30000348-763659BD-772A-4159-8451-6A1AB5DADD69 Q30241943-E4DBA879-E0F5-4E9E-BC74-B8671E952CBC Q30701525-980B7A3F-EFD3-43D3-864E-4929937AB4B0 Q30823934-2D807BE8-2DB2-4AFA-B1EB-A31708980CC4 Q33466544-2143D0AE-C135-4E50-BAB6-F3902420AF22 Q33896092-F8083703-F84A-4EFF-AFE3-A57D81793D0A Q34485836-908395E2-4E98-4A52-8544-F39551C55AFF Q34530470-1B2F5CCA-17FE-459C-B1F3-AEF8E3BE6B04 Q35362267-F14F15EB-763E-4A43-A3D0-3EF7C09C6109 Q35916925-30049BAE-C9E8-4CDD-B393-EE6BD8B4A517 Q35938274-545562DC-2CC2-4DE0-9839-8B57E7774E30 Q36068996-8A759A0F-56A6-4217-83B0-285EC99D9F55 Q36107299-8FA9D169-3FF3-4659-8577-0FABEE01ED94 Q36136449-349BC16B-C734-439C-922D-12D88BA5BE02 Q36166971-AF4E5CE6-5607-4F6E-A5C3-7B65930B5844 Q36186252-A60FD18D-2500-4BE3-9526-A1C39236EC31 Q36287039-C4763039-3CD2-434E-A91F-0E0C1927B8A1 Q36366979-C3F1E771-C4AE-4D3A-9233-4D2F3A3A4816 Q36379436-A11A801A-033F-4CDB-A9CE-4BC4469438C3 Q36405917-D8E61A32-EE6C-4826-8871-4957D6E1ABBB Q36430696-0CAD5DFE-6D54-4C75-9ACA-4C7577015316 Q36444070-EA6107C8-BC1A-40B0-BEF8-282EDB3DA83F Q36462205-95C0ED15-B5FB-430F-B06C-24C91417FE2B Q36604243-4E5DA905-9C55-4F56-AA88-E656A7F130C9 Q36814629-5280EF59-5316-4880-9E11-5406DBE73442 Q37057113-CE3DCC28-6D43-4910-9975-A98CEC565441 Q37662940-CAB9AFDE-557A-4BDB-8F90-963DFED2A6C0 Q38379623-DBD87A68-1192-460B-B238-B5BFEBEF95B4 Q38392764-0FFF7341-C6B0-454D-BFB0-E5FB1C06B07C

P2860

Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

http://www.wikidata.org/entity/Q47431942

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@en

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@nl

type

label

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@en

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@nl

prefLabel

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@en

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@nl

P1433

Q47431942-8E605DC6-3436-4ABB-8911-EFF4D72AFEA8

P1476

Q47431942-76DBEFBB-A3E7-41F6-800B-51964A091F1E

P2093

Q47431942-07AE51AF-CD63-4777-BB42-2B6CB57BF512

Q47431942-0E885CD1-95FD-4ED9-A89A-D9B48CB50958

Q47431942-26397105-79F8-4F14-B79B-47B5E422A0C2

Q47431942-31C27EEF-27C3-4C61-B3FC-72DAA887C822

Q47431942-34DD3BDA-8DFC-462A-9237-C20678FD9CC5

Q47431942-3BF60E9E-1098-4CA3-BE65-DB3A13FF67AC

Q47431942-3D67E1D6-E4B2-41DD-BBC6-4A07C5B84A8D

Q47431942-46488DE4-5840-48E8-9447-1DB7E742FB2E

Q47431942-860C5C0A-F22B-4538-A592-0A614FE3E554

Q47431942-91E7575A-F63C-45BD-B583-5B8A2F5AAF93

P304

Q47431942-1B8C942D-C5B9-44DB-97A8-F62D26E6B877

P31

Q47431942-A44912FA-A14F-40D1-97F7-D6524F65F7C3

P356

Q47431942-0CE1F346-2888-4CB7-A5EA-41191C870B6A

P433

Q47431942-611D8B66-144B-4DDB-A7F6-B975373267E6

P478

Q47431942-6868CA62-A181-47A1-8AA5-9FB9D464C9FA

P50

Q47431942-51648123-0D9F-4A72-9A1C-202272AC935D

Q47431942-55D564EB-4488-4E0B-9EB5-F2D63BDF6F8B

Q47431942-D73EE746-B743-4EA8-BA8B-E755D74912C2

P577

Q47431942-326B9A25-3C60-4D3F-840D-DFD2BDE16290

P5875

Q47431942-0903D722-6DED-4D4C-A960-8C535BED86AC

P698

Q47431942-C58BDF65-787C-4BC4-8917-603A9040DF9D

P921

Q47431942-15d98708-8e5e-412b-bae4-e6cd719ab118

Q47431942-3486BD73-3E65-4215-83D0-4708D59B03BA

Q47431942-736C5CCE-EF50-4329-B7B0-C31B3B8D09BF

P356

J.CMET.2014.08.002

P1433

Cell Metabolism

P1476

Obesity-induced CerS6-dependen ...... gain and glucose intolerance.

@en

P2093

Aleksandra Trifunovic

http://www.w3.org/2001/XMLSchema#string

Arnaud Mourier

http://www.w3.org/2001/XMLSchema#string

Claudia M Wunderlich

http://www.w3.org/2001/XMLSchema#string

Diana M Willmes

http://www.w3.org/2001/XMLSchema#string

Elaine Xu

http://www.w3.org/2001/XMLSchema#string

F Thomas Wunderlich

http://www.w3.org/2001/XMLSchema#string

Giuseppe LoSasso

http://www.w3.org/2001/XMLSchema#string

Hayley T Nicholls

http://www.w3.org/2001/XMLSchema#string

Hella S Brönneke

http://www.w3.org/2001/XMLSchema#string

Jan Mauer

http://www.w3.org/2001/XMLSchema#string

P304

678-686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2014.08.002

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Blüher

Jan-Wilhelm Kornfeld

Jens C Brüning

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266625280

http://www.w3.org/2001/XMLSchema#string

P698

25295788

http://www.w3.org/2001/XMLSchema#string

P921